Foundayo Opens GLP-1 Oral Obesity Treatment Market

Eli Lilly's Foundayo received FDA approval April 1, with cash pricing set at $149 monthly (matching oral Wegovy) and Medicare coverage starting summer at $50 monthly. Projected 2030 sales of $14.8 billion.